CoChat

Baseline serum 25‐hydroxyvitamin D concentrations in the Tromsø Study 1994–95 and risk of developing type 2 diabetes mellitus during 11 years of follow‐up

Open access
Grimnes, G., Emaus, N., Joakimsen, R. M., Figenschau, Y., Jenssen, T., Njølstad, I., Schirmer, H., Jorde, R. · 2010 · Diabetic Medicine
Cited by 122

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Diabet. Med. 27, 1107–1115 (2010) Aims We wanted to test the hypothesis that low serum 25‐hydroxyvitamin D (25(OH)D) concentrations are associated with increased risk of developing Type 2 diabetes mellitus (DM) in a population‐based cohort during 11 years of follow‐up. Methods The analyses included 4157 non‐smokers and 1962 smokers from the Tromsø Study 1994–95 without diabetes at baseline. Subsequent Type 2 DM was defined using a hospital journal‐based end‐point registry, completed through the year 2005. Participants were allocated into quartiles of serum 25(OH)D within each month to account for seasonal variation, and serum 25(OH)D values both as a continuous variable and in quartiles were used in Cox regression models. The analyses were stratified by smoking. Adjustments were made for age, sex, body mass index (BMI), physical activity and, in non‐smokers, former smoking. Results Type 2 DM was registered in 183 non‐smoking and 64 smoking participants. Using the fourth (highest) quartile of serum 25(OH)D as the reference, non‐smoking participants in the third, second and first quartiles had age‐ and sex‐adjusted hazard ratios (95% confidence intervals) of incident Type 2 DM of 1.00 (0.62–1.61), 1.50 (0.97–2.31) and 1.89 (1.25–2.88), respectively, whereas the corresponding values for smokers were 1.79 (0.77–4.19), 2.33 (1.02–5.35) and 2.68 (1.18–6.08). Adjustment for BMI attenuated the hazard ratios, and they were no longer significant. Conclusions Baseline serum 25(OH)D was inversely associated with subsequent Type 2 DM in a population‐based 11 year follow‐up study, but not after adjustment for BMI. Randomized trials are needed to define the possible role of serum 25(OH)D status, and thereby the role of supplementation, in the prevention of Type 2 DM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2010.03092.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 122

Metadata

Authors
Grimnes, G., Emaus, N., Joakimsen, R. M., Figenschau, Y., Jenssen, T., Njølstad, I., Schirmer, H., & Jorde, R.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2010-07-21
Volume
27
Issue
10
Pages
1107-1115
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W1605721024
Cited by
122
References
5
FWCI
9.04
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Baseline serum 25‐hydroxyvitamin D concentrations in the Tromsø Study 1994–95 and risk of developing type 2 diabetes mellitus during 11 years of follow‐up. https://app.cochat.ai/papers/10.1111/j.1464-5491.2010.03092.x
The paper
Grimnes, G., Emaus, N., Joakimsen, R. M., Figenschau, Y., Jenssen, T., Njølstad, I., Schirmer, H., & Jorde, R. (2010). Baseline serum 25‐hydroxyvitamin D concentrations in the Tromsø Study 1994–95 and risk of developing type 2 diabetes mellitus during 11 years of follow‐up. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2010.03092.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.